Accessibility Menu

RetinalGenix Technologies

(OTC) RTGN

Current Price$4.00
Market Cap$75.37M
Since IPO (2022)+33%
5 YearN/A
1 Year+10%
1 Month+0%

RetinalGenix Technologies Financials at a Glance

Market Cap

$75.37M

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.43M

EPS (TTM)

-$0.13

P/E Ratio

-30.53

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.00

Volume

19

Open

$4.00

Previous Close

$4.00

Daily Range

$4.00 - $4.00

52-Week Range

$3.20 - $4.01

Estimated Earnings Date

Mar 31, 2023

RTGN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RetinalGenix Technologies

Industry

Healthcare Equipment and Supplies

CEO

Jerry Katzman, MD

Headquarters

Apollo Beach, CA 94954, US

RTGN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-23%

Return on Assets

-419%

Earnings Yield

-3.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$75.37M

Shares Outstanding

18.84M

Volume

19

Avg. Volume

12.781

Financials (TTM)

Gross Profit

$0.00

Operating Income

$0.00

EBITDA

$0.00

Operating Cash Flow

-$558.35K

Capital Expenditure

$0.00

Free Cash Flow

-$558.35K

Cash & ST Invst.

$14.77K

Total Debt

$55.54K

RetinalGenix Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$75.37M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$590.49K

-0.6%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

-$54.89K

-4.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.21K

-49.8%

Short Term Debt

$51.86K

+3.7%

Return on Assets

-418.92%

N/A

Return on Invested Capital

-22.95%

N/A

Free Cash Flow

-$109.21K

+41.7%

Operating Cash Flow

-$109.21K

+41.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HITCHealthcare Integrated Technologies, Inc.
$0.30+0.00%
INNPFINNOCAN PHARMA Corp
$2.45-2.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.38-0.13%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
KEELKeel Infrastructure
$5.13-0.13%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%

Questions About RTGN

What is the current price of RetinalGenix Technologies?

RetinalGenix Technologies is trading at $4.00 per share.

What is the 52-week range for RetinalGenix Technologies?

Over the past 52 weeks, RetinalGenix Technologies has traded between $3.20 and $4.01.

How much debt does RetinalGenix Technologies have?

As of the most recent reporting period, RetinalGenix Technologies reported total debt of $55.07K.

How much cash does RetinalGenix Technologies have on hand?

RetinalGenix Technologies reported $180.00 in cash and cash equivalents in its most recent financial results.

What is RetinalGenix Technologies’s dividend yield?

RetinalGenix Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.